CDI Bioscience

About:

CDI Biosciences develops technologies that increase the yield of bioproducts manufactured in cellular systems.

Website: http://www.cdibiotech.com/

Top Investors: Battelle Ventures, Innovation Valley Partners

Description:

CDI Bioscience has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bioproducts.